Eurocine Vaccines´ Chlamydia vaccine candidate elicits both antibody and T cell responses
In the latest preclinical study, it was shown that intramuscular immunization with the Chlamydia vaccine candidate elicits an excellent T cell response, in addition to the previously confirmed antibody responses. Achieving this combination of antibodies and T cells indicates that our vaccine candidate generates an effective barrier, which can prevent infection as well as promote clearance of infected cells.Our studies have to date shown that parenteral immunization generates much stronger antibody responses than mucosal immunization. The latest study shows that vaccination elicits CD4+ and